Search Cancer Clinical Trials

The Cancer Center offers patients access to a wide variety of clinical trials of promising new therapies. Use the search tool to find open protocols for your type of cancer.
25 results
  • Breast Cancer, Cervical Cancer, Ovarian Cancer, Head and Neck Cancer

21-689          Phase I

A First-in-Human Study of Mutant-selective PI3Ka Inhibitor, RLY-2608, as a Single Agent in Advanced Solid Tumor Patients and in Combination With Fulvestrant in Patients With Advanced Breast Cancer (View details on clinicaltrial.gov)

  • Head and Neck Cancer, Lymphoma, Melanoma, Lung Cancer

21-258          Phase II

A Multicenter Phase 1-2A Study to Assess the Safety, Tolerability, Pharmacokinetics, and Antitumor Activity of LNS8801 in Patients With Advanced Cancer With and Without Pembrolizumab (View details on clinicaltrial.gov)

  • Breast Cancer, Leukemia, Head and Neck Cancer, Sarcoma, Ovarian Cancer, Metastatic/Advanced Cancer, Lymphoma

20-035          Phase II

A Multi-Center, Open Label Phase 1/2 Study of CYT-0851, an Oral RAD51 Inhibitor, in Patients With Relapsed/Refractory B-Cell Malignancies and Advanced Solid Tumors (View details on clinicaltrial.gov)

  • Lung Cancer, Head and Neck Cancer, Bladder Cancer, Melanoma

18-418          Phase III

A Multicenter, Open label, Phase III Extension Trial to Study the Long-term Safety and Efficacy in Participants with Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab Trial. (View details on clinicaltrial.gov)

  • Lung Cancer, Breast Cancer, Head and Neck Cancer, Cervical Cancer, Ovarian Cancer, Esophageal Cancer

22-281          Phase I

A Phase 1 Study Investigating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Preliminary Antitumor Activity of Second Mitochondrial-derived Activator of Caspases Mimetic BGB-24714 as Monotherapy and in Combination With Chemotherapy in Patients With Advanced or Metastatic Solid Tumors (View details on clinicaltrial.gov)

  • Lung Cancer, Thyroid Cancer, Head and Neck Cancer

22-124          Phase I

A Phase 1 Study of Oral LOXO-260 in Patients with RET Fusion-Positive Solid Tumors, Medullary Thyroid Cancer, and Other Tumors with RET Activation Refractory to Selective RET Inhibitors (View details on clinicaltrial.gov)

  • Head and Neck Cancer

19-374          Phase I

A Phase 1, First-in-Human, Open-Label, Dose Escalation and Expansion Study of CUE-101 Monotherapy in Second Line and CUE-101 Combination Therapy with Pembrolizumab in First Line Patients with HPV16+ Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (HNSCC) (View details on clinicaltrial.gov)

  • Lung Cancer, Melanoma, Metastatic/Advanced Cancer, Head and Neck Cancer

21-332          Phase I

A Phase 1/1b Study of MPT-0118 as Monotherapy and in Combination with Pembrolizumab in Subjects with Advanced or Metastatic Solid Tumors (View details on clinicaltrial.gov)

  • Colorectal Cancer, Endometrial Cancer, Ovarian Cancer, Head and Neck Cancer, Lung Cancer

21-060          Phase II

A Phase 1/2 Study Evaluating the Safety, Tolerability and Preliminary Antitumor Activity of COM701 in Combination with BMS-986207 (anti-TIGIT antibody) and Nivolumab in Subjects with Advanced Solid Tumors (View details on clinicaltrial.gov)

  • Head and Neck Cancer, Lung Cancer, Thyroid Cancer

17-241          Phase I

A Phase 1/2 Study of Oral LOXO-292 in Patients with Advanced Solid Tumors, Including RET Fusion-Positive Solid Tumors, Medullary Thyroid Cancer, and Other Tumors with RET Activation (LIBRETTO-001) (View details on clinicaltrial.gov)

Showing 1 - 10 of 25 results